Cancer Family
Malignant Head and Neck Neoplasm
CI-CAN-00000236Explore in graph →
1,432 active trials17 approved drugs142 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000236Explore in graph →
Clinical trials
5,449 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (629)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02563470 | Bleeding, Cardio- and Cerebrovascular Complications in Head and Neck Surgery | completed | — | 456 | University of TurkuOTHER | 0 | Sep 30, 2015 | clinicaltrials |
| NCT02068950 | Progressive Resistance Training Program in Head and Neck Cancer Patients | completed | N/A | 12 | Herlev HospitalOTHER | 1 | Sep 25, 2015 | clinicaltrials |
| Study of Chemotherapy Combined With Nimotuzumab in Untreated Metastatic Nasopharyngeal Carcinoma |
| completed |
| Phase 2 |
| 39 |
| Sun Yat-sen UniversityOTHER |
| 1 |
| Sep 22, 2015 |
| clinicaltrials |
| NCT01678105 | A Phase II Study of Dovitinib in Recurrent and/or Metastatic Adenoid Cystic Carcinoma of the Salivary Glands(DOVE) | completed | Phase 2 | 21 | Ontario Clinical Oncology Group (OCOG)OTHER | 1 | Sep 17, 2015 | clinicaltrials |
| NCT00337129 | S0618 E7389 in Treating Patients With Metastatic or Recurrent Head and Neck Cancer | completed | Phase 2 | 42 | National Cancer Institute (NCI)NIH | 1 | Aug 25, 2015 | clinicaltrials |
| NCT01584284 | Safety Study of Attenuated Vaccinia Virus (GL-ONC1)With Combination Therapy in Head & Neck Cancer | completed | Phase 1 | 19 | Genelux CorporationINDUSTRY | 1 | Aug 25, 2015 | clinicaltrials |
| NCT01192204 | Clinical Evaluation of Bioadhesive Gels for Oral Cancer Chemoprevention | completed | Phase 1 / Phase 2 | 41 | Ohio State UniversityOTHER | 1 | Aug 14, 2015 | clinicaltrials |
| NCT02199132 | Retrospective Study About Nasopharyngeal Carcinoma at C. S. Parc Tauli | completed | — | 50 | Corporacion Parc TauliOTHER | 1 | Aug 3, 2015 | clinicaltrials |
| NCT01816919 | Characterization of Head and Neck Malignant Tumors Using an Electronic Nose(HNeNose) | completed | N/A | 100 | Carmel Medical CenterOTHER | 0 | Jul 31, 2015 | clinicaltrials |
| NCT00696176 | STAT3 DECOY in Head and Neck Cancer | completed | Early Phase 1 | 32 | University of PittsburghOTHER | 1 | Jul 23, 2015 | clinicaltrials |
| NCT00886132 | A Study of Sunitinib in Recurrent and/or Metastatic Adenoid Cystic Carcinoma of the Salivary Glands | completed | Phase 2 | 14 | University Health Network, TorontoOTHER | 1 | Jul 23, 2015 | clinicaltrials |
| NCT01317589 | Treatment of Pain in Head-and-Neck Cancer Patients: is Methadone More Effective?(310111-4) | completed | Phase 4 | 134 | Maastricht University Medical CenterOTHER | 1 | Jul 16, 2015 | clinicaltrials |
| NCT00706316 | Administration of Epstein Barr Virus - Specific Cytotoxic T-Lymphocytes to Metastatic EBV-Positive Nasopharygneal Cancer(NPC-CTL) | completed | Phase 1 | 5 | University Health Network, TorontoOTHER | 1 | Jul 10, 2015 | clinicaltrials |
| NCT01116843 | Study to Assess Biomarkers in Patients With Resectable Oral Cavity Cancer Randomized to Receive Preoperative Treatment | completed | Phase 1 / Phase 2 | 13 | University Health Network, TorontoOTHER | 1 | Jul 10, 2015 | clinicaltrials |
| NCT01484847 | A Study of PF-00299804 When Given Through a Feeding Tube in Locally Advanced Head and Neck Squamous Cell Carcinoma | completed | N/A | 6 | University Health Network, TorontoOTHER | 1 | Jul 10, 2015 | clinicaltrials |
| NCT01012258 | Cetuximab With Radiotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck in Chinese Subjects(CHANCE) | completed | Phase 3 | 70 | Merck KGaA, Darmstadt, GermanyINDUSTRY | 1 | Jul 9, 2015 | clinicaltrials |
| NCT01039272 | Epstein-Barr Detection in Oral Cancer | completed | — | 60 | UPECLIN HC FM Botucatu UnespOTHER | 1 | Jun 25, 2015 | clinicaltrials |
| NCT01275183 | Pilot Study of Raltegravir and Cisplatin in Squamous Cell Carcinoma of Head and Neck | completed | Early Phase 1 | 5 | New Mexico Cancer Research AllianceOTHER | 1 | Jun 18, 2015 | clinicaltrials |
| NCT01310179 | Safety Study of Adenovirus/PNP Coupled With Fludarabine Phosphate to Treat Solid Tumors | completed | Phase 1 | 12 | PNP Therapeutics, Inc.INDUSTRY | 1 | Jun 10, 2015 | clinicaltrials |
| NCT00281840 | Bevacizumab, Docetaxel, and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer | completed | Phase 2 | 30 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 9, 2015 | clinicaltrials |
| NCT01907997 | Effects of Systemic Lidocaine on Postoperative Quality of Recovery After Robot-assisted Thyroidectomy | completed | N/A | 90 | Yonsei UniversityOTHER | 1 | Jun 9, 2015 | clinicaltrials |
| NCT00508664 | Docetaxel, Cisplatin (TP) + Radiation +/- Cetuximab in Larynx Carcinoma (CA)(DeLOS II) | completed | Phase 2 | 180 | ClinAssessOTHER | 2 | Jun 2, 2015 | clinicaltrials |
| NCT00186433 | A Longitudinal Study of Plasma EBV DNA in Nasopharyngeal Carcinoma From Both Endemic and Non-Endemic Patient Populations | completed | — | 49 | Stanford UniversityOTHER | 1 | May 27, 2015 | clinicaltrials |
| NCT01952821 | Validity and Reliability of Outcome Measures in Patients With Cancer of the Head and Neck | completed | — | 66 | Mayo ClinicOTHER | 1 | May 22, 2015 | clinicaltrials |
| NCT00570232 | UAB 0718 - Phase II Trial to Assess Target Oral Therapy as Adjuvant Chemoprevention in High-Risk Head and Neck Cancer(UAB0718) | completed | Phase 2 | 31 | University of Alabama at BirminghamOTHER | 1 | May 21, 2015 | clinicaltrials |
| NCT01152840 | Study of RAD001 in Adenoid Cystic Carcinoma(ACCRAD001) | completed | Phase 2 | 33 | Seoul National University HospitalOTHER | 1 | May 20, 2015 | clinicaltrials |
| NCT01794481 | Benefits of Exercise Training in Head and Neck Cancer Patients Undergoing Organ-Preserving Definitive Therapy | completed | N/A | 24 | University of Michigan Rogel Cancer CenterOTHER | 1 | May 20, 2015 | clinicaltrials |
| NCT00827164 | Resistance Training During Radiation Therapy for Pharyngeal or Laryngeal Cancer | completed | Phase 2 | 29 | University of Alabama at BirminghamOTHER | 1 | May 12, 2015 | clinicaltrials |
| NCT00147732 | Randomized Trial of ARCON in Larynx Cancer | completed | Phase 3 | 345 | Radboud University Medical CenterOTHER | 2 | May 7, 2015 | clinicaltrials |
| NCT00160095 | Patient Selection for Hypoxia Modifying Treatments in Larynx Carcinomas | completed | — | 79 | Radboud University Medical CenterOTHER | 1 | May 7, 2015 | clinicaltrials |
| NCT00458978 | Cediranib Maleate in Treating Patients With Recurrent or Newly Diagnosed Metastatic Head and Neck Cancer | completed | Phase 2 | 6 | National Cancer Institute (NCI)NIH | 1 | May 5, 2015 | clinicaltrials |
| NCT00006981 | Immunotoxin Therapy in Treating Patients With Advanced Cancer | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Apr 30, 2015 | clinicaltrials |
| NCT00021424 | Vaccine Therapy in Treating Patients With Stage IV Head and Neck Cancer | completed | Phase 1 | — | National Institute on Deafness and Other Communication Disorders (NIDCD)NIH | 1 | Apr 30, 2015 | clinicaltrials |
| NCT00066651 | Immunotoxin Therapy in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Apr 30, 2015 | clinicaltrials |
| NCT00019110 | Vaccine Therapy in Treating Patients With Advanced or Recurrent Cancer | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Apr 29, 2015 | clinicaltrials |
| NCT00019201 | Fluorescent Light Bronchoscopy Plus White Light Bronchoscopy for Early Detection of Lung Cancer | completed | N/A | — | National Cancer Institute (NCI)NIH | 1 | Apr 29, 2015 | clinicaltrials |
| NCT00713219 | Docetaxel + Cetuximab + Concurrent Re-Irradiation (Intensity - Modulated Radiation Therapy, IMRT) for Patients With Locoregionally Recurrent Head and Neck Cancer | completed | Phase 2 | 14 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Apr 23, 2015 | clinicaltrials |
| NCT01129037 | Goal Directed Fluid Therapy in Free Flap Reconstructive Surgery | completed | N/A | 78 | University Health Network, TorontoOTHER | 1 | Apr 21, 2015 | clinicaltrials |
| NCT00114283 | Lapatinib Ditosylate in Treating Patients With Metastatic or Recurrent Head and Neck Cancer | completed | Phase 2 | 30 | National Cancer Institute (NCI)NIH | 1 | Apr 15, 2015 | clinicaltrials |
| NCT00206752 | Study of Unilateral Neck Irradiation in Patients With SCC of the Head and Neck(Unilateral) | completed | N/A | 45 | Beth Israel Medical CenterOTHER | 1 | Mar 30, 2015 | clinicaltrials |
| NCT01853670 | Adaptive Radiation Therapy for Head & Neck Cancer Patients(IGRT) | completed | N/A | 6 | Beth Israel Medical CenterOTHER | 1 | Mar 30, 2015 | clinicaltrials |
| NCT01228565 | Trial of OTD70DERM® in Radio-dermatitis Induced by Radiotherapy-Erbitux®(GORTEC 2009-01) | completed | Phase 3 | 76 | Groupe Oncologie Radiotherapie Tete et CouOTHER | 1 | Mar 24, 2015 | clinicaltrials |
| NCT01424358 | Web-based Education on Oral Cancer for Primary Care Physicians in Ohio | completed | N/A | 10 | Creighton UniversityOTHER | 1 | Mar 24, 2015 | clinicaltrials |
| NCT01736163 | A Retrospective Observational Study Comparing Two Different Treatment Options in Thyroid Cancer Patients With T4 Tumours | completed | — | 144 | Genzyme, a Sanofi CompanyINDUSTRY | 4 | Mar 23, 2015 | clinicaltrials |
| NCT01790204 | A Study of the Effects of PEITC on Oral Cells With Mutant p53 | completed | Phase 1 / Phase 2 | 55 | Georgetown UniversityOTHER | 1 | Mar 23, 2015 | clinicaltrials |
| NCT00584129 | Pre-treatment Exercises Versus Post-treatment Exercises for Dysphagia | completed | N/A | 52 | University of Alabama at BirminghamOTHER | 1 | Mar 17, 2015 | clinicaltrials |
| NCT02050503 | Intranasal Transmucosal Fentanyl Pectin for Breakthrough Cancer Pain in Radiation-induced Oropharyngeal Mucositis(CP073) | completed | — | 33 | Grupo de Investigación Clínica en Oncología RadioterapiaOTHER | 1 | Mar 17, 2015 | clinicaltrials |
| NCT01596933 | Effect of Omega-3 Supplements on the Prevention of Cachexia in Head and Neck Cancer Treated With Radio(Chemo)Therapy(NUTRIOM) | completed | Phase 2 / Phase 3 | 91 | General Hospital GroeningeOTHER | 1 | Mar 10, 2015 | clinicaltrials |
| NCT01334177 | TLR8 Agonist VTX-2337 and Cetuximab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Squamous Cell Cancer of Head and Neck | completed | Phase 1 | 13 | University of WashingtonOTHER | 1 | Mar 5, 2015 | clinicaltrials |
Data updated 23 days agoSource updated Sep 30, 2015source: clinicaltrials